An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Saedisomeolia A, Samadi M, Gholami F, Seyedi M, Effatpanah M, Hashemi R, Abdolahi M, Honarvar NM.Saedisomeolia A, et al. Among authors: abdolahi m.CNS Neurol Disord Drug Targets. 2018;17(4):280-290. doi: 10.2174/1871527317666180501111627.CNS Neurol Disord Drug Targets. 2018.PMID: 29714151Review.
Reza Dorosty-Motlagh A, Mohammadzadeh Honarvar N, Sedighiyan M, Abdolahi M.Reza Dorosty-Motlagh A, et al. Among authors: abdolahi m.J Mol Neurosci. 2016 Sep;60(1):82-90. doi: 10.1007/s12031-016-0781-0. Epub 2016 Jun 29.J Mol Neurosci. 2016.PMID: 27356515Review.
Mohammadzadeh Honarvar N, Saedisomeolia A, Abdolahi M, Shayeganrad A, Taheri Sangsari G, Hassanzadeh Rad B, Muench G.Mohammadzadeh Honarvar N, et al. Among authors: abdolahi m.J Mol Neurosci. 2017 Mar;61(3):289-304. doi: 10.1007/s12031-016-0857-x. Epub 2016 Nov 18.J Mol Neurosci. 2017.PMID: 27864661Review.
Soveyd N, Abdolahi M, Djalali M, Hatami M, Tafakhori A, Sarraf P, Honarvar NM.Soveyd N, et al. Among authors: abdolahi m.CNS Neurol Disord Drug Targets. 2018 Mar 13;16(10):1120-1126. doi: 10.2174/1871527317666171213154749.CNS Neurol Disord Drug Targets. 2018.PMID: 29237386Clinical Trial.
Abdolahi M, Sarraf P, Javanbakht MH, Honarvar NM, Hatami M, Soveyd N, Tafakhori A, Sedighiyan M, Djalali M, Jafarieh A, Masoudian Y, Djalali M.Abdolahi M, et al.CNS Neurol Disord Drug Targets. 2018;17(6):430-438. doi: 10.2174/1871527317666180625101643.CNS Neurol Disord Drug Targets. 2018.PMID: 29938621Clinical Trial.
Hatami M, Abdolahi M, Soveyd N, Djalali M, Togha M, Honarvar NM.Hatami M, et al. Among authors: abdolahi m.Endocr Metab Immune Disord Drug Targets. 2019;19(3):247-258. doi: 10.2174/1871530319666181129103056.Endocr Metab Immune Disord Drug Targets. 2019.PMID: 30488803Review.
Sedighiyan M, Djafarian K, Dabiri S, Abdolahi M, Shab-Bidar S.Sedighiyan M, et al. Among authors: abdolahi m.CNS Neurol Disord Drug Targets. 2019;18(7):523-529. doi: 10.2174/1871527318666190516083008.CNS Neurol Disord Drug Targets. 2019.PMID: 31096898
Seyedi M, Gholami F, Samadi M, Djalali M, Effatpanah M, Yekaninejad MS, Hashemi R, Abdolahi M, Chamari M, Honarvar NM.Seyedi M, et al. Among authors: abdolahi m.CNS Neurol Disord Drug Targets. 2019;18(6):496-501. doi: 10.2174/1871527318666190703103709.CNS Neurol Disord Drug Targets. 2019.PMID: 31269890Clinical Trial.